Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Short Candidates -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (527)	5/28/2003 9:41:42 AM
From: tuck	Respond to of 897

Geron: Here's the snip about the warrants from the 8-K: >>On May 23, 2003, Geron Corporation, a Delaware corporation (the "Company"), entered into a Restructuring Agreement (the "Restructuring Agreement") with the holder (the "Investor") of its Series D Convertible Debentures (the "Debentures"). Before the transaction, the Debentures had a principal amount of $15.0 million and had accrued $575,342 in interest. Pursuant to the Restructuring Agreement, the Debentures were amended (i) to add the accrued interest to principal and eliminate future interest accruals, (ii) to provide for a fixed conversion price of $5.00 per share, and (iii) to provide for a mandatory conversion on June 30, 2005 of any Debentures not previously converted, so long as the Company had complied with the terms of the Debentures. The Restructuring Agreement also provided for the amendment of the warrants previously issued to the Investor in connection with the Debentures. The Series D-1 warrants to purchase 333,935 shares of the Company's Common Stock, expiring June 30, 2003, and the Series D-2 warrants to purchase 500,901 shares of the Company's Common Stock, expiring December 31, 2006, were each amended to change the exercise price to $7.50 per share.<< Going to short a half position of GERN right here at $5.27. Also a full position of VXGN at $6.1 the current bid. Most other picks have been kicking BSCP's butt. Will that last, or will the summer bring it relief? Most biofreaks would prefer the former, I know. Cheers, Tuck